Max Mobility recalled 8,413 Smart Drive MX2+ SpeedControl Dials on August 12, 2025. A faulty electrical connection poses a risk of losing control of the wheelchair, leading to potential injuries. Healthcare providers should stop using the device immediately and follow recall instructions.
Due to a faulty electrical connection between the speed control Dial and the wheelchair motor, their is a potential for lost of control of the device potentially resulting in minor or major injuries.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Max Mobility LLC or your healthcare provider for instructions. Notification method: Letter
The recall affects all serial numbers of the Smart Drive MX2+ SpeedControl Dial Ref: MX2-3DCMC distributed between April 25, 2022, and July 8, 2025. The devices were sold in the U.S. and internationally, including Canada, New Zealand, and several other countries.
A faulty electrical connection between the speed control dial and the wheelchair motor may cause the device to lose control. This defect has a high hazard classification, indicating a significant risk of injury.
The recall documentation does not specify the number of reported injuries, but the potential for minor or major injuries exists due to the loss of control.
Stop using the Smart Drive MX2+ immediately. Follow the recall instructions provided by Max Mobility and contact your healthcare provider for further guidance.
For more information, visit the Max Mobility recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2540-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.